The Hearing Journal by D'Anne Rudden The Hearing Journal

Dr. Rudden and Dr. Scholl continue the conversation on the Aftershow with lessons learned from a meeting with legislators, how to avoid burnout, and ways to stay educated on the top issues affecting audiology.
 
Learn more about SoundWrx.

Dr. Scholl is the Founder and Executive Director of SoundWrx, a non-profit in Tulsa, Okla., with the goal to educate, inspire, and demonstrate the unlimited abilities of people with hearing loss and give them the opportunity to live inclusively and to their full potential. She is also the Head of Pediatrics for Tuned, an online platform providing audiology care. Dr. Scholl joins the podcast this month to talk about her passion for advocacy and how audiologists can get involved.
 
Learn more about SoundWrx.

The conversation continues on the Aftershow with Drs. Swanepoel and Rudden. Listen to their discussion on a community-based, public health approach to patient care, as well as the ethics around teleaudiology.

Dr. De Wet Swanepoel joins Dr. D’Anne Rudden this month to discuss how audiologists can meet their patients in more accessible ways through teleaudiology. Dr. Swanepoel is Professor of Audiology at the University of Pretoria, South Africa, and an adjunct professor in Otolaryngology-Head & Neck Surgery at the University of Colorado School of Medicine. He is Editor-in-Chief of the International Journal of Audiology and founder of a digital health company called hearX group.

The conversation continues on the Aftershow with Drs. Zwolan and Goldstein. Listen to their discussion on the challenges of coding and reimbursement, speech-in-noise testing, and the MTSB-3 guidelines.  
For more on the MTSB-3 guidelines, visit www.cochlearimplanttraining.com.

Dr. Terry Zwolan is the Director of Audiology Access and Standards of Care at Cochlear Americas. Dr. Mary Rose Goldstein is an audiologist at the Ear and Hearing Center in the Center for Neurosciences in Tucson, Arizona. They join Dr. D’Anne Rudden on the podcast this month to decode cochlear implant candidacy guidelines, the MTSB, and “best aided condition.”